Company / Free Cash Flow
Arcutis Biotherapeutics, Inc. Free Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$6.3M
FY2025
5-year range
-$258.0M / -$6.3M
FY2021-FY2025
Trend
+94.4%
vs FY2024
Sector context
#68 of 194
Health Care
What the data says
At -$6M, Arcutis Biotherapeutics, Inc.'s free cash flow ranks #68 of 194 in the Health Care sector. Free Cash Flow has increased for 3 consecutive years, from -$258M in FY2022 to -$6M in FY2025.
Based on SEC 10-K filings.
-$6M in FY2025.
Improved from -$247M to -$6M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#68 of 194 in Health CareTop 35% of 194This company -$6.3M Sector average $470.8M
▼
-101.3% below sector average
Key checks
Key Insights
- Arcutis Biotherapeutics, Inc.'s free cash flow has grown for 3 consecutive years.
- In FY2025, free cash flow increased 94.4% year-over-year.
- Ranks #68 out of 194 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.3M | +94.4% |
| FY2024 | -$112.3M | +54.6% |
| FY2023 | -$247.5M | +4.1% |
| FY2022 | -$258.0M | -46.9% |
| FY2021 | -$175.6M | -54.9% |
| FY2020 | -$113.4M | -162.8% |
| FY2019 | -$43.1M | -206.2% |
| FY2018 | -$14.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026